Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Stanley

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Blood|March 26, 2016
Ectopic DNMT3B expression delays leukemogenesisRobert F Stanley, Ulrich Steidl
Cancer Discovery|April 6, 2016
Molecular Mechanism of Mutant CALR-Mediated TransformationRobert F Stanley, Ulrich Steidl
Nature Cancer|May 27, 2022
Dysregulation and therapeutic targeting of RNA splicing in cancerRobert F Stanley, Omar Abdel-Wahab
Genetics|November 19, 2008
Curing of yeast [URE3] prion by the Hsp40 cochaperone Ydj1p is mediated by Hsp70Deepak Sharma, Robert F Stanley, Daniel C Masison
Blood|July 15, 2015
PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndromeAshley Pandolfi, Robert F Stanley, Yiting Yu, et al.
Science Advances|January 2, 2026
Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulatorsAristeidis G Telonis, Robert F Stanley, Emmalee R Adelman, et al.
The Journal of Experimental Medicine|February 25, 2017
A myeloid tumor suppressor role for <i>NOL3</i>Robert F Stanley, Richard T Piszczatowski, Boris Bartholdy, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
A mitochondrial surveillance mechanism activated by <i>SRSF2</i> mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Nature Immunology|April 9, 2013
Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitmentBritta Will, Thomas O Vogler, Boris Bartholdy, et al.
The Journal of Clinical Investigation|May 7, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Blood|March 26, 2016
Ectopic DNMT3B expression delays leukemogenesisRobert F Stanley, Ulrich Steidl
Cancer Discovery|April 6, 2016
Molecular Mechanism of Mutant CALR-Mediated TransformationRobert F Stanley, Ulrich Steidl
Nature Cancer|May 27, 2022
Dysregulation and therapeutic targeting of RNA splicing in cancerRobert F Stanley, Omar Abdel-Wahab
Genetics|November 19, 2008
Curing of yeast [URE3] prion by the Hsp40 cochaperone Ydj1p is mediated by Hsp70Deepak Sharma, Robert F Stanley, Daniel C Masison
Blood|July 15, 2015
PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndromeAshley Pandolfi, Robert F Stanley, Yiting Yu, et al.
Science Advances|January 2, 2026
Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulatorsAristeidis G Telonis, Robert F Stanley, Emmalee R Adelman, et al.
The Journal of Experimental Medicine|February 25, 2017
A myeloid tumor suppressor role for <i>NOL3</i>Robert F Stanley, Richard T Piszczatowski, Boris Bartholdy, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
A mitochondrial surveillance mechanism activated by <i>SRSF2</i> mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Nature Immunology|April 9, 2013
Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitmentBritta Will, Thomas O Vogler, Boris Bartholdy, et al.
The Journal of Clinical Investigation|May 7, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Pageof 2